The U.S. has been pushing for an end to the nearly four-year war, but has failed to broker a compromise between Moscow and Kyiv on the key issue of territory Author of the article: You can save this ...

Litifilimab significantly improved skin disease activity in CLE, with a CLASI-A score difference from placebo of up to -33.4 percentage points. The Food and Drug Administration (FDA) has granted ...

Breakthrough therapy designation targets the post-CDK4/6 setting in PIK3CA-mutant HR+/HER2− advanced disease, where progression is common and therapeutic options remain constrained. Phase 1/2 ...

Test your knowledge of credit cards, buying a home, saving for college or retirement and other things that affect your wallet. By Connie Chang and Juli Fraga Illustrations by Jay Daniel Wright Making ...

When life feels scattered or spiritually dry, sometimes the most powerful thing we can do is return to Scripture—one verse at a time. The Daily Bible Verses for February is a peaceful, Scripture-first ...

Sofi-cel, an allogeneic CAR-T therapy, targets CD7 and uses CRISPR/Cas9 to prevent fratricide and reduce graft-versus-host disease risk. The FDA's breakthrough therapy designation facilitates ...

Lucy Lazarony is an experienced personal finance journalist and writer who got her start in 1998 writing about financial topics. She writes accessible and easy-to-understand articles about credit, ...

Samsung has unveiled its new processor technology, a system-on-a-chip geared toward smartphones that could impact its own upcoming product lineup. Exynos 2600 is a chip that combines a CPU, an ...

In wealth management, the gravitational pull toward RIAs hasn't slowed down. Advisors continue to peel away from wirehouses and brokerage firms in favor of the independence, flexibility and ...

More than half of Americans plan to ring in 2026 with a financial resolution, but only about two in five think they’ll actually stick with it, according to the new Financial New Year’s Resolution ...

The Food and Drug Administration granted breakthrough therapy designation to Arrowhead Pharmaceuticals' plozasiran drug to treat severe hypertriglyceridemia. The designation expedites the development ...

The Christmas season has a special way of turning our hearts back to God’s promises—and what better way to center each day in truth than with a Scripture reading plan rooted in His Word? Daily Bible ...